241 related articles for article (PubMed ID: 28672788)
1. N-3 Polyunsaturated Fatty Acids Decrease the Protein Expression of Soluble Epoxide Hydrolase via Oxidative Stress-Induced P38 Kinase in Rat Endothelial Cells.
Okada T; Morino K; Nakagawa F; Tawa M; Kondo K; Sekine O; Imamura T; Okamura T; Ugi S; Maegawa H
Nutrients; 2017 Jun; 9(7):. PubMed ID: 28672788
[No Abstract] [Full Text] [Related]
2. Duality of n-3 Polyunsaturated Fatty Acids on Mcp-1 Expression in Vascular Smooth Muscle: A Potential Role of 4-Hydroxy Hexenal.
Nagayama K; Morino K; Sekine O; Nakagawa F; Ishikado A; Iwasaki H; Okada T; Tawa M; Sato D; Imamura T; Nishio Y; Ugi S; Kashiwagi A; Okamura T; Maegawa H
Nutrients; 2015 Sep; 7(9):8112-26. PubMed ID: 26402697
[TBL] [Abstract][Full Text] [Related]
3. 4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation.
Ishikado A; Morino K; Nishio Y; Nakagawa F; Mukose A; Sono Y; Yoshioka N; Kondo K; Sekine O; Yoshizaki T; Ugi S; Uzu T; Kawai H; Makino T; Okamura T; Yamamoto M; Kashiwagi A; Maegawa H
PLoS One; 2013; 8(7):e69415. PubMed ID: 23936010
[TBL] [Abstract][Full Text] [Related]
4. 4-Hydroxy hexenal derived from dietary n-3 polyunsaturated fatty acids induces anti-oxidative enzyme heme oxygenase-1 in multiple organs.
Nakagawa F; Morino K; Ugi S; Ishikado A; Kondo K; Sato D; Konno S; Nemoto K; Kusunoki C; Sekine O; Sunagawa A; Kawamura M; Inoue N; Nishio Y; Maegawa H
Biochem Biophys Res Commun; 2014 Jan; 443(3):991-6. PubMed ID: 24361890
[TBL] [Abstract][Full Text] [Related]
5. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium.
Xue H; Wan M; Song D; Li Y; Li J
Vascul Pharmacol; 2006 Jun; 44(6):434-9. PubMed ID: 16616699
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid and eicosapentaenoic acid suppress adhesion molecule expression in human aortic endothelial cells via differential mechanisms.
Huang CY; Sheu WH; Chiang AN
Mol Nutr Food Res; 2015 Apr; 59(4):751-62. PubMed ID: 25631736
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase.
Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY
Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891
[TBL] [Abstract][Full Text] [Related]
8. The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation.
Cui PH; Petrovic N; Murray M
Br J Pharmacol; 2011 Mar; 162(5):1143-55. PubMed ID: 21077851
[TBL] [Abstract][Full Text] [Related]
9. Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice.
Mavrommatis Y; Ross K; Rucklidge G; Reid M; Duncan G; Gordon MJ; Thies F; Sneddon A; de Roos B
Br J Nutr; 2010 Jan; 103(1):16-24. PubMed ID: 19674494
[TBL] [Abstract][Full Text] [Related]
10. A diet rich in omega-3 fatty acids enhances expression of soluble epoxide hydrolase in murine brain.
Ostermann AI; Reutzel M; Hartung N; Franke N; Kutzner L; Schoenfeld K; Weylandt KH; Eckert GP; Schebb NH
Prostaglandins Other Lipid Mediat; 2017 Nov; 133():79-87. PubMed ID: 28583889
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries.
Limbu R; Cottrell GS; McNeish AJ
PLoS One; 2018; 13(2):e0192484. PubMed ID: 29394279
[TBL] [Abstract][Full Text] [Related]
12. Effect of the double bond conjugation on the vascular physiology and nitric oxide production of isomers of eicosapentaenoic and docosahexaenoic acids prepared from shark oil.
Gonzalez C; Silva-Ramirez AS; Navarro-Tovar G; Barrios-Capuchino JJ; Rocha-Uribe A
PLoS One; 2020; 15(2):e0229435. PubMed ID: 32107491
[TBL] [Abstract][Full Text] [Related]
13. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase: A potential target for metabolic diseases.
He J; Wang C; Zhu Y; Ai D
J Diabetes; 2016 May; 8(3):305-13. PubMed ID: 26621325
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 polyunsaturated fatty acids reduce vascular endothelial growth factor production and suppress endothelial wound repair.
Zhuang W; Wang G; Li L; Lin G; Deng Z
J Cardiovasc Transl Res; 2013 Apr; 6(2):287-93. PubMed ID: 22993129
[TBL] [Abstract][Full Text] [Related]
16. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation.
Dasilva G; Pazos M; García-Egido E; Gallardo JM; Rodríguez I; Cela R; Medina I
J Nutr Biochem; 2015 Nov; 26(11):1385-92. PubMed ID: 26320676
[TBL] [Abstract][Full Text] [Related]
17. Tetramethylpyrazine suppresses angiotensin II-induced soluble epoxide hydrolase expression in coronary endothelium via anti-ER stress mechanism.
Mak SK; Yu CM; Sun WT; He GW; Liu XC; Yang Q
Toxicol Appl Pharmacol; 2017 Dec; 336():84-93. PubMed ID: 29066182
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase: gene structure, expression and deletion.
Harris TR; Hammock BD
Gene; 2013 Sep; 526(2):61-74. PubMed ID: 23701967
[TBL] [Abstract][Full Text] [Related]
19. A novel mechanism of ascorbate direct modulation of soluble epoxide hydrolase.
Zhang B; Kandhi S; Yang YM; Le Y; Deng W; Qin J; Jiang H; Froogh G; Sun D; Huang A
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():59-66. PubMed ID: 28827137
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.
Ulu A; Harris TR; Morisseau C; Miyabe C; Inoue H; Schuster G; Dong H; Iosif AM; Liu JY; Weiss RH; Chiamvimonvat N; Imig JD; Hammock BD
J Cardiovasc Pharmacol; 2013 Sep; 62(3):285-97. PubMed ID: 23676336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
